NCT02122562View on ClinicalTrials.gov

Ketamine Alcohol (in Treatment-Resistant Depression)

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 23, 2014

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Magnetic Resonance ImagingMajor DepressionAlcoholism
Interventions
DRUG

Ketamine

Treatment

Trial Locations (1)

52242

RECRUITING

University of Iowa Health Care, Iowa City

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Mark Niciu

OTHER

NCT02122562 - Ketamine Alcohol (in Treatment-Resistant Depression) | Biotech Hunter | Biotech Hunter